Figure 1. Efficacy of JPH203 due to L-type amino acid transporter 1 (LAT1)-substrate inhibition. (A) Progression-free survival. (B) Overall survival. The degree of inhibition of uptake of the LAT1-substrate plasma free amino acids (PFAAs) was divided into high and low inhibition groups by the median. Black line, high inhibition group. Dotted line, low inhibition group. CI: Confidence interval.